Ku munsi wa 1, Februray, Shanghai Chuangkun Biotechnology Co., Ltd. yabonye icyemezo cya kabiri cyo kwiyandikisha muri Tayilande FDA kubikoresho byo gutahura igituntu / NTM-ADN, byatewe nigikoresho 15 cyo mu bwoko bwa HPV cyerekana PCR ukwezi kumwe gushize.ryatangaje ko ibicuruzwa bya Chuangkun Biotech byemewe na Tayilande FDA, biteza imbere ibicuruzwa byateje imbere, ndetse binatanga inkunga ikomeye kuri Chuangkun Biotech mu rwego rwo kurushaho kwagura isoko mpuzamahanga.
Bivugwa ko ku isi hose abantu bagera kuri miliyoni 10,6 barwaye igituntu cyashyizwe ahagaragara na OMS mu 2021.Ikiyongera cyiyongereyeho 4.5% ugereranyije n’umwaka wa 2020. Hagati aho abantu miliyoni 1.6 bapfuye bazize igituntu umwaka ushize (harimo 6.7% bari mu babana na virusi itera SIDA) .Mu rwego rw'isi, abantu benshi banduye igituntu mu 2021 bari mu turere twa OMS muri Aziya y'Amajyepfo-Uburasirazuba (45%), Afurika (23%) na Pasifika y'Iburengerazuba (18%), bafite imigabane mito mu burasirazuba bwa Mediterane (8.1%), Amerika (2.9%) n'Uburayi (2,2%).Urebye icyorezo cya COVID-19, kwirinda igituntu no kurwanya indwara birakaze cyane kuri gahunda yo guhagarika igituntu kuri OMS.
Igikoresho cya TB / NTM-ADN ya CHUANGKUN Biotech cyakozwe nuburyo bwa lyophilisation Inzira izakemura ibibazo byogutwara igihe kirekire kubikoresho gakondo bya PCR, kandi bizana ibisobanuro nyabyo nibisubizo bihanitse cyane kuruta amasezerano yo gukoresha.
Shanghai Chuangkun Biotechnology Co., Ltd yabonye icyemezo cya kabiri cyo kwiyandikisha muri Tayilande FDA kubikoresho byo gutahura igituntu / NTM-ADN, byerekana ko byemewe na Tayilande FDA.Chuangkun Biotech izahindura mugukumira igituntu mukarere no kurwanya cyane.
Igihe cyo kohereza: Gashyantare-02-2023